Tariro Makadzange is a Physician Scientist with an MD from Harvard Medical School and PhD (DPhil) in Immunology from University of Oxford. Her specialist clinical training is in Internal Medicine (University of Washington) and Infectious Diseases (Massachusetts General Hospital and Brigham and Women’s Hospital). She is an experienced academic researcher and public health leader. She co-founded the Parirenyatwa Hospital Family Care Centre which became one of the largest HIV treatment programs in Zimbabwe. She established a clinical research program conducting clinical research and multi-site implementation science research studies and basic immunology research. She was faculty at Harvard Medical School/Massachusetts General Hospital in Infectious Diseases and established a research partnership that resulted in the establishment of the Infectious Diseases Research Laboratory in Harare. The lab conducts basic immunology and virology research in infectious diseases pertinent to the developing world. Her academic research work spanned seminal work on management of HIV and coinfections, outcomes research for paediatric, adolescent, and adult HIV infection through to basic immunology including antibody discovery. After a career in academia, she transitioned to Industry where she worked at Gilead Sciences in clinical development and discovery research. Recognizing the need for expertise in pandemic responsiveness and clinical trials in Africa she established the Charles River Medical Group and Mutala research. CRMG is a clinical research organization focused on diversifying research by including Africa and Africans in medical clinical trials while Mutala is a non-profit public health research organization conducting public health and implementation science research in infectious diseases. She is an Adjunct Assistant Professor in Clinical Medicine at Stanford University, and Faculty Fellow at the Center for Innovation and Global Health at Stanford.
